Tag: kidney cancer

The Challenges and Successes of Sorafenib Clinical Trials

Sorafenib was the first targeted therapy to extend survival in advanced liver and kidney cancer. Despite tough side effects and limited response rates, it gave patients crucial time and paved the way for newer treatments.